174 related articles for article (PubMed ID: 23799110)
1. Overexpression of RBBP6, alone or combined with mutant TP53, is predictive of poor prognosis in colon cancer.
Chen J; Tang H; Wu Z; Zhou C; Jiang T; Xue Y; Huang G; Yan D; Peng Z
PLoS One; 2013; 8(6):e66524. PubMed ID: 23799110
[TBL] [Abstract][Full Text] [Related]
2. High Expressions of CUL4A and TP53 in Colorectal Cancer Predict Poor Survival.
Li C; Bu J; Liao Y; Zhang J; Han J; Zhang H; Xing H; Li Z; Wu H; Liang L; Wang M; Qin W; Yang T
Cell Physiol Biochem; 2018; 51(6):2829-2842. PubMed ID: 30562757
[TBL] [Abstract][Full Text] [Related]
3. IMP3 is a novel prognostic marker that correlates with colon cancer progression and pathogenesis.
Li D; Yan D; Tang H; Zhou C; Fan J; Li S; Wang X; Xia J; Huang F; Qiu G; Peng Z
Ann Surg Oncol; 2009 Dec; 16(12):3499-506. PubMed ID: 19672661
[TBL] [Abstract][Full Text] [Related]
4. Expression analysis and association of RBBP6 with apoptosis in colon cancers.
Dlamini Z; Rupnarain C; Naicker S; Hull R; Mbita Z
J Mol Histol; 2016 Apr; 47(2):169-82. PubMed ID: 26905308
[TBL] [Abstract][Full Text] [Related]
5. Determination of TP53 mutation is more relevant than microsatellite instability status for the prediction of disease-free survival in adjuvant-treated stage III colon cancer patients.
Westra JL; Schaapveld M; Hollema H; de Boer JP; Kraak MM; de Jong D; ter Elst A; Mulder NH; Buys CH; Hofstra RM; Plukker JT
J Clin Oncol; 2005 Aug; 23(24):5635-43. PubMed ID: 16110022
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the expression and association of retinoblastoma binding protein 6 with the JNK signaling pathway in prostate cancers.
Guan WY; Zhao S; Luo YN
Cell Biol Int; 2020 Oct; 44(10):2107-2119. PubMed ID: 32662898
[TBL] [Abstract][Full Text] [Related]
7. Ubiquitin-like with PHD and ring finger domains 2 is a predictor of survival and a potential therapeutic target in colon cancer.
Lu S; Yan D; Wu Z; Jiang T; Chen J; Yuan L; Lin J; Peng Z; Tang H
Oncol Rep; 2014 Apr; 31(4):1802-10. PubMed ID: 24573556
[TBL] [Abstract][Full Text] [Related]
8. Msi-1 is a predictor of survival and a novel therapeutic target in colon cancer.
Li D; Peng X; Yan D; Tang H; Huang F; Yang Y; Peng Z
Ann Surg Oncol; 2011 Jul; 18(7):2074-83. PubMed ID: 21442350
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of prothymosin-α, independently or combined with TP53, correlates with poor prognosis in colorectal cancer.
Zhang M; Cui F; Lu S; Lu H; Jiang T; Chen J; Zhang X; Jin Y; Peng Z; Tang H
Int J Clin Exp Pathol; 2014; 7(8):4867-76. PubMed ID: 25197357
[TBL] [Abstract][Full Text] [Related]
10. Expression and function of retinoblastoma binding protein 6 (RBBP6) in human lung cancer.
Motadi LR; Bhoola KD; Dlamini Z
Immunobiology; 2011 Oct; 216(10):1065-73. PubMed ID: 21676486
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of Tim-3 is associated with poor prognosis of patients with colon cancer.
Zhou E; Huang Q; Wang J; Fang C; Yang L; Zhu M; Chen J; Chen L; Dong M
Int J Clin Exp Pathol; 2015; 8(7):8018-27. PubMed ID: 26339368
[TBL] [Abstract][Full Text] [Related]
12. Comparative proteomics analysis of gastric cancer stem cells.
Morisaki T; Yashiro M; Kakehashi A; Inagaki A; Kinoshita H; Fukuoka T; Kasashima H; Masuda G; Sakurai K; Kubo N; Muguruma K; Ohira M; Wanibuchi H; Hirakawa K
PLoS One; 2014; 9(11):e110736. PubMed ID: 25379943
[TBL] [Abstract][Full Text] [Related]
13. Karyopherin alpha 2 is a novel prognostic marker and a potential therapeutic target for colon cancer.
Zhang Y; Zhang M; Yu F; Lu S; Sun H; Tang H; Peng Z
J Exp Clin Cancer Res; 2015 Dec; 34():145. PubMed ID: 26626145
[TBL] [Abstract][Full Text] [Related]
14. COLORECTAL Polymeric Immunoglobulin Receptor Expression is Correlated with Hepatic Metastasis and Poor Prognosis in Colon Carcinoma Patients with Hepatic Metastasis.
Liu F; Ye P; Bi T; Teng L; Xiang C; Wang H; Li Y; Jin K; Mou X
Hepatogastroenterology; 2014 May; 61(131):652-9. PubMed ID: 26176052
[TBL] [Abstract][Full Text] [Related]
15. De-regulation of the RBBP6 isoform 3/DWNN in human cancers.
Mbita Z; Meyer M; Skepu A; Hosie M; Rees J; Dlamini Z
Mol Cell Biochem; 2012 Mar; 362(1-2):249-62. PubMed ID: 22139301
[TBL] [Abstract][Full Text] [Related]
16. RBBP6 aggravates the progression of ovarian cancer by targeting PIK3R6.
Liu YJ; Cui LL; Liu ZS; Jia RY; Ding YX; Xu LZ
Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10366-10374. PubMed ID: 33155192
[TBL] [Abstract][Full Text] [Related]
17. RBBP6, a RING finger-domain E3 ubiquitin ligase, induces epithelial-mesenchymal transition and promotes metastasis of colorectal cancer.
Xiao C; Wu G; Zhou Z; Zhang X; Wang Y; Song G; Ding E; Sun X; Zhong L; Li S; Weng J; Zhu Z; Chen J; Wang X
Cell Death Dis; 2019 Nov; 10(11):833. PubMed ID: 31685801
[TBL] [Abstract][Full Text] [Related]
18. Increased microRNA-34b and -34c predominantly expressed in stromal tissues is associated with poor prognosis in human colon cancer.
Hiyoshi Y; Schetter AJ; Okayama H; Inamura K; Anami K; Nguyen GH; Horikawa I; Hawkes JE; Bowman ED; Leung SY; Harris CC
PLoS One; 2015; 10(4):e0124899. PubMed ID: 25894979
[TBL] [Abstract][Full Text] [Related]
19. Clinical application of oligonucleotide probe array for full-length gene sequencing of TP53 in colon cancer.
Takahashi Y; Ishii Y; Nagata T; Ikarashi M; Ishikawa K; Asai S
Oncology; 2003; 64(1):54-60. PubMed ID: 12457032
[TBL] [Abstract][Full Text] [Related]
20. Silencing RBBP6 (Retinoblastoma Binding Protein 6) sensitises breast cancer cells MCF7 to staurosporine and camptothecin-induced cell death.
Moela P; Choene MM; Motadi LR
Immunobiology; 2014 Aug; 219(8):593-601. PubMed ID: 24703106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
